H. Lee Moffitt Cancer Center and Research Institute: all 539 studies

Page 5 of 6. Open to participants first (74), then studies with results posted, then the rest; newest registration first within each.

• Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine TumorsCompletedNCT02948946
• Capecitabine and Lenvatinib With External Radiation in Rectal AdenocarcinomaCompletedNCT02935309Phase 1
• Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT)CompletedNCT02851056Early Phase 1
• Hypofractionated Stereotactic Irradiation With Nivolumab, Ipilimumab and Bevacizumab in Patients With Recurrent High Grade GliomasCompletedNCT02829931Phase 1
• Oncology Research Information Exchange Network (ORIEN) Lung Cancer StudyCompletedNCT02803333
• Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,PanobinostatWithdrawnNCT02802163Phase 1/2
• A Combined Cell Therapy Approach to the Treatment of NeuroblastomaWithdrawnNCT02745756Phase 1
• Validation Study on the Impact of Decipher® Testing - VANDAAM StudyActive, not recruitingNCT02723734
• XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV MelanomaActive, not recruitingNCT02721459Phase 1
• Pilot Testing of a Real-Time Oncogeriatric Teleconsultation System Using the Total Cancer Care™ DatabaseCompletedNCT02708381
• Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic MelanomaCompletedNCT02652455Early Phase 1
• Smoking-cessation: A Spanish-Language Clinical TrialCompletedNCT02611076Not applicable
• Dose Escalation Study of Preoperative SBRT for High Risk Prostate CancerCompletedNCT02572284Phase 1
• Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the LungWithdrawnNCT02466568Phase 1/2
• Genetic Counseling for Breast Cancer Survivors (GC for BC)CompletedNCT02451735Not applicable
• Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate CancerCompletedNCT02415621Early Phase 1
• A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AMLCompletedNCT02403310Phase 1
• A Phase I/II Trial of HER-2/Neu Pulsed DC1 Vaccine Combined With Trastuzumab for Patients With DCISWithdrawnNCT02336984Phase 1/2
• Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular CancerCompletedNCT02292173Phase 1
• Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal EsophagusTerminatedNCT02283359Phase 1
• Capitalizing on a Teachable Moment to Promote Smoking CessationCompletedNCT02276664Not applicable
• Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain MetastasesTerminatedNCT02187822Phase 1
• Navigator Guided e-Psychoeducational InterventionCompletedNCT02186444
• Stereotactic Body Radiotherapy and Concurrent Cisplatin for Re-Irradiation of Unresectable, Recurrent Squamous Cell Carcinomas of Head and NeckCompletedNCT02158234Phase 1
• BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic CancerCompletedNCT02155088Phase 1
• Enzalutamide in Combination With Gemcitabine and Nab-Paclitaxel for the Treatment of Advanced Pancreatic CancerCompletedNCT02138383Phase 1
• HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant ChemotherapyCompletedNCT02061423Phase 1
• Biomarker Correlates of Hypoxia in Metastatic MelanomaWithdrawnNCT02061007Phase 2
• Physical Activity for Advanced Stage Cancer PatientsCompletedNCT02015936Not applicable
• Yoga for Aromatase Inhibitor-associated Joint PainCompletedNCT01951976Not applicable
• Randomized Controlled Trial of Endoscopic Dilation: Triamcinolone InjectionCompletedNCT01873573Not applicable
• A Phase I/IB Trial of MEK162 in Combination With Erlotinib in NSCLC Harboring KRAS or EGFR MutationCompletedNCT01859026Phase 1
• Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related PainTerminatedNCT01846429Phase 1
• Colorectal Cancer Awareness, Research, Education and Screening (CARES)CompletedNCT01804179Not applicable
• A Phase I Dose Escalation Study of Eribulin Plus Weekly Carboplatin for Metastatic Breast PatientsCompletedNCT01795586Phase 1
• Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host DiseaseCompletedNCT01795573Phase 1
• Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility StudyCompletedNCT01760499Phase 1
• Ruxolitinib in Combination With Nilotinib in Chronic Myeloid Leukemia (CML) PatientsCompletedNCT01702064Phase 1
• Sorafenib and Topotecan in Refractory/Recurrent Pediatric MalignanciesCompletedNCT01683149Phase 1
• Evaluating Biobanking Educational ToolsCompletedNCT01672944Not applicable
• Brentuximab Vedotin in CD30 Positive Epstein Barr Virus (EBV) Positive DLBCL of ElderlyWithdrawnNCT01671813Not applicable
• Protocol for High-Risk Assessment, Screening, and Early Detection of Pancreatic CancerCompletedNCT01662609
• Study of XL888 With Vemurafenib for Patients With Unresectable BRAF Mutated Stage III/IV MelanomaCompletedNCT01657591Phase 1
• Smoking Relapse-Prevention Intervention for Cancer PatientsCompletedNCT01630161Not applicable
• Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial CarcinomaCompletedNCT01606345Phase 1
• Stress Management Training for Latinas Receiving ChemotherapyCompletedNCT01599520Not applicable
• Metformin in Children With Relapsed or Refractory Solid TumorsCompletedNCT01528046Phase 1
• Evaluation of Image-guided Brushing of Pancreatic Cyst Wall in Diagnosis of Cystic Pancreatic TumorsTerminatedNCT01455311
• Vitamin E δ-Tocotrienol Multiple Dose in Healthy SubjectsCompletedNCT01450046Phase 1
• Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy SubjectsCompletedNCT01446952Phase 1
• Phase II Study of First-line SBRT in Patients With Non-Metastatic Unresectable Pancreatic CancerWithdrawnNCT01434550Not applicable
• Phase I Trial of Combination of FOLFIRI and SOM 230CompletedNCT01434069Phase 1
• Effects of Yoga and Cardiovascular Exercise on Smoking MotivationCompletedNCT01423578Not applicable
• Pilot Study on Focal Prostate Radio-Frequency AblationCompletedNCT01423006Not applicable
• Pilot Study of Strength and Balance Training Program for Persons With Oxaliplatin Induced NeuropathyCompletedNCT01422993Not applicable
• Promoting a Healthier Lifestyle Among Breast Cancer SurvivorsCompletedNCT01419613Not applicable
• Pilot Program to Personalize Care & Improve Quality of Life for Women With Ovarian CancerCompletedNCT01419210Not applicable
• Managing Medication-induced Constipation in Cancer: A Clinical TrialCompletedNCT01416909Not applicable
• Pilot Study of a Geriatric Intervention After Colorectal and Lung Cancer SurgeryCompletedNCT01416168Not applicable
• SOM 230 and Gemcitabine in Advanced Pancreatic CancerCompletedNCT01385956Phase 1
• Pre-operative 5-Fluorouracil (5-FU) and Sorafenib With External Radiation in Locally Advanced Rectal CancerCompletedNCT01376453Phase 1
• Extended Self-Help for Smoking CessationCompletedNCT01352195Not applicable
• Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline")CompletedNCT01352000Not applicable
• Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL)CompletedNCT01324180Phase 1
• C11 AMT Positron Emission Tomography (PET) Imaging in Patients With Metastatic Invasive Breast CancerWithdrawnNCT01302821Not applicable
• Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With ThrombocytopeniaTerminatedNCT01286038Phase 1
• Facts and Attitudes About Clinical TrialsCompletedNCT01269645Not applicable
• Carboplatin/Taxol/Ridaforolimus in Endometrial, Ovarian and SolidsCompletedNCT01256268Phase 1
• Gem-TABS in Unresectable Pancreatic CarcinomaCompletedNCT01198821Phase 1
• Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV MelanomaCompletedNCT01176474Phase 1
• Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558CompletedNCT01176461Phase 1
• FOLFOX/Bevacizumab +/- MK-0646 in Metastatic Colorectal CancerWithdrawnNCT01175291Phase 2
• Vertebral Augmentation With Kyphoplasty vs Nonsurgical Mgmt for Vertebral Body Compression FracturesWithdrawnNCT01175278Not applicable
• Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100CompletedNCT01008527Phase 1
• Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine NeoplasiaCompletedNCT00985777Phase 1
• Study Bendamustine Concurrent Whole Brain Radiation Brain Metastases From Solid TumorsTerminatedNCT00879073Phase 1
• Immunotherapy Using Lenalidomide + Bystander Vaccine in High Risk Myelodysplastic Syndrome (MDS)CompletedNCT00840931Phase 1
• The Human Papillomavirus (HPV) Transmission Pilot StudyCompletedNCT00823511
• Evaluation of Patient Functionality and Utility of Web-Based Personal Health History and Risk AssessCompletedNCT00822822
• Liposuction for Arm Lymphedema Following Breast Cancer SurgeryCompletedNCT00816985Not applicable
• Drug /Cue Interactions In Alcohol-Tobacco ComorbidityCompletedNCT00816231Not applicable
• Decision Making in Unaffected First-Degree Relatives of Prostate Cancer PatientsCompletedNCT00815750Not applicable
• Pilot Study to Validate Metallic Markers for Image Guided Radiation Therapy for Breast Cancer TxCompletedNCT00802932
• Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells MaturedCompletedNCT00798629Phase 1
• Natural History of HPV Infection in Men: The HIM StudyCompletedNCT00786760
• A Phase I Trial of Vorinostat in Combination With Bevacizumab & Irinotecan in Recurrent GlioblastomaCompletedNCT00762255Phase 1
• Support for People Undergoing ChemotherapyCompletedNCT00740038Not applicable
• Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract CancersCompletedNCT00738751Phase 1
• The Specific Role of Isoflavones in Reducing Prostate Cancer RiskCompletedNCT00617617Phase 2
• A Phase I/II Study of Sunitinib and DacarbazineTerminatedNCT00496223Phase 1/2
• A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic CancerCompletedNCT00480584Phase 1
• Phase I Dasatinib/Erlotinib in Recurrent Non-small Cell Lung Cancer (NSCLC)CompletedNCT00444015Phase 1
• Phase I Study of Temozolomide, Valproic Acid and Radiation Therapy in Patients With Brain MetastasesTerminatedNCT00437957Phase 1
• Patient Navigator ProjectCompletedNCT00375024Not applicable
• Phase II Study of Temozolomide in Newly Diagnosed GlioblastomaTerminatedNCT00365222Phase 2
• A Combination of Zarnestra With Velcade for Patients With Relapsed Multiple MyelomaTerminatedNCT00361088Phase 1/2
• Phase I/II Trial of Valproic Acid and Karenitecin for MelanomaTerminatedNCT00358319Phase 1/2
• Phase I Trial of Intratumoral pIL-12 Electroporation in Malignant MelanomaCompletedNCT00323206Not applicable
• Dendritic Cell Vaccination During Lymphoid ReconstructionCompletedNCT00313508Phase 1
• Phase I Trial of Valproic Acid and Epirubicin in Solid Tumor MalignanciesCompletedNCT00246103Phase 1

← H. Lee Moffitt Cancer Center and Research Institute overview and focus areas